{
    "title": "Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 bln",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8879357/Bayer-acquire-Asklepios-Bio-foray-gene-therapy-worth-4-bln.html",
    "date": "2020-10-26",
    "keywords": [
        "bayer",
        "development",
        "gene",
        "therapy",
        "askbio",
        "drug",
        "disease",
        "burger",
        "cell",
        "advisor",
        "counsel",
        "inc",
        "bet",
        "help",
        "milestone",
        "contingent",
        "monday",
        "north",
        "takeover",
        "target",
        "harmless",
        "virus",
        "delivery",
        "device",
        "repair",
        "range",
        "body",
        "maker",
        "pipeline",
        "outlook",
        "settlement",
        "weedkiller",
        "cancer",
        "buildup",
        "sugar",
        "molecule",
        "heart",
        "failure",
        "deal",
        "acquisition",
        "bluerock",
        "developer",
        "stem",
        "intention",
        "business",
        "information",
        "collaborate",
        "pledge",
        "firm",
        "board",
        "structure",
        "ability",
        "science",
        "officer",
        "cofounder",
        "sheila",
        "mikhail",
        "capital",
        "minority",
        "stake",
        "company",
        "research",
        "production",
        "fee",
        "treatment",
        "duchenne",
        "dystrophy",
        "pfizer",
        "month",
        "httpswwwpfizercomnewspressreleasepressreleasedetailpfizerreceivesfdafasttrackdesignationduchenne",
        "status",
        "boost",
        "decline",
        "credit",
        "suisse",
        "baker",
        "mckenzie",
        "jp",
        "morgan",
        "gray",
        "reporting"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}